Kura Oncology, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$3,794,833
30 notices · 368,073 sh
Oct 2025 to Oct 2026
Reported ·
$2,134,573
28 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
7 of 28 reported sales carry the 10b5-1 box. Together they are 0.24% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-09-29BRIAN POWL, Chief Commercial Officer$163,712
2026-09-29MOLLIE LEONI, Chief Medical Officer$305,589
2026-09-29KATHLEEN FORD, Chief Operating Officer$38,917
2026-09-28BRIAN POWL, Chief Commercial Officer$86,080
2026-09-28POWL BRIAN T, Chief Commercial Officer$97,055
2026-09-28FORD KATHLEEN, Chief Operating Officer$74,309
2026-09-28BAIR TERESA BROPHY, Chief Legal Officer$90,836
2026-09-28LEONI MOLLIE, Chief Medical Officer$133,940
2026-09-28DOYLE THOMAS JAMES, SVP, Finance & Accounting$49,571
2026-09-24FRANCIS J BURROWS, Chief Scientific Officer$224,514
2026-08-21BRIAN POWL, Chief Commercial Officer$50,880
2026-08-19TERESA BAIR, Chief Legal Officer$388,235
2026-06-18MOLLIE VANESSA LEONI, Chief Medical Officer$812,771
Form 4, 2026-06-22: sold 84,929 at $9.82 Form 4 ↗
2026-05-21BRIAN POWL, Chief Commercial Officer$103,400
Form 4, 2026-05-22: sold 10,000 at $11.00 Form 4 ↗
2026-05-19KATHLEEN FORD, Chief Operating Officer$20,764
Form 4, 2026-05-20: sold 2,257 at $9.08 Form 4 ↗
2026-05-19BRIAN POWL, Chief Commercial Officer$3,119
Form 4, 2026-05-20: sold 339 at $9.21 Form 4 ↗
2026-05-18TERESA BAIR, Chief Legal Officer$20,800
Form 4, 2026-05-20: sold 2,256 at $9.38 Form 4 ↗
2026-01-27POWL BRIAN T, Chief Commercial Officer$54,327
Form 4, 2026-01-27: sold 6,414 at $8.46 Form 4 ↗
2026-01-27BAIR TERESA BROPHY, Chief Legal Officer$94,932
Form 4, 2026-01-27: sold 11,208 at $8.46 Form 4 ↗
2026-01-27FORD KATHLEEN, Chief Operating Officer$15,356
Form 4, 2026-01-27: sold 1,813 at $8.46 Form 4 ↗
2026-01-27LEONI MOLLIE, Chief Medical Officer$69,285
Form 4, 2026-01-27: sold 8,180 at $8.46 Form 4 ↗
2026-01-27BURROWS FRANCIS, Chief Scientific Officer$11,104
Form 4, 2026-01-27: sold 1,311 at $8.46 Form 4 ↗
2026-01-27DOYLE THOMAS JAMES, SVP, Finance & Accounting$60,493
Form 4, 2026-01-27: sold 7,142 at $8.46 Form 4 ↗
2025-12-18FRANCIS J BURROWS, Chief Scientific Officer$231,934
Form 4, 2025-12-19: sold 23,726 at $9.78 Form 4 ↗
2025-12-09FAHEEM HASNAIN, Director$116,400
Form 4, 2025-12-10: sold 10,000 at $10.98 Form 4 ↗
2025-11-14FORD KATHLEEN, Chief Operating Officer$73,713
Form 4, 2025-11-14: sold 6,902 at $11.18 Form 4 ↗
2025-11-14DOYLE THOMAS JAMES, SVP, Finance & Accounting$48,477
Form 4, 2025-11-14: sold 4,539 at $11.18 Form 4 ↗
2025-11-14POWL BRIAN T, Chief Commercial Officer$94,913
Form 4, 2025-11-14: sold 8,887 at $11.18 Form 4 ↗
2025-11-14BAIR TERESA BROPHY, Chief Legal Officer$94,027
Form 4, 2025-11-14: sold 8,804 at $11.18 Form 4 ↗